SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Jan. 30, 2021	Feb. 01, 2020
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	384,757	796,725
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	0
Number of Underlying Shares, Forfeited or expired (in shares)	(411,968)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 33.04	$ 40.06
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0
Weighted-Average Exercise Price, Exercised (in dollars per share)	0
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 46.63
Aggregate Intrinsic Value, Outstanding	$ 177,195
Weighted-Average Remaining Contractual Life, Outstanding	3 years 2 months 12 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	384,757
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 33.04
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 177,195
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	3 years 2 months 12 days
Number of Underlying Shares, Stock appreciation rights expected to become exercisable (in shares)	0
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable (in dollars per share)	$ 0
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 0
Weighted-Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	0 years